At the news
? NEUTRALIMPACT 2/10 3 filed Nov 3, 2026 at 14:40 ET
Paul J. Diaz filed a Form 3 initial statement of beneficial ownership with the SEC, reporting 200 shares of Merck common stock held directly and 96 shares held indirectly through a revocable trust. The filing is a routine Section 16 compliance requirement for a new officer or director and contains no material financial information.
- Paul J. Diaz filed Form 3 on 2026-11-03, reporting beneficial ownership as of 2026-11-01.
- Direct holdings: 200 shares of Merck common stock.
- Indirect holdings: 96 shares held through Reporting Person's Revocable Trust.
- The filing includes a Power of Attorney authorizing Jennifer Zachary, Jon Filderman, and Kelly Grez to file Section 16 reports on his behalf.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access